Prenatal screenings that analyze small amounts of fetal DNA found in maternal blood samples may be more accurate at detecting congenital defects than conventional methods, according to a study in the New England Journal of Medicine. In test results for 2,000 pregnancies, cell-free DNA tests produced false positives at a rate 10 times lower than that of standard screening measures performed later in pregnancy.
Maternal blood tests reduce false positives in prenatal screening, study finds
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan